FSImultiform 1..21


LANSEN PHARMACEUTICAL HOLDINGS LIMITED

朗 生 醫 藥 控 股 有 限 公 司

(incorporated in the Cayman Islands with limited liability)

(Stock code: 503)

FORM OF PROXY

FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON 21 JUNE 2016

I/We(Note 1) of being the registered holder(s) of (Note2) ordinary share(s) of US$0.01 each in the capital of Lansen Pharmaceutical Holdings Limited (the ''Company''), hereby appoint the Chairman of the annual general meeting of the Company, or

(note 3)



of as my/our proxy to attend and vote for me/us and on my/our behalf at the annual general meeting of the Company (the ''Meeting'') to be held at Admiralty Conference Centre (ACC), 1804A, 18/F, Tower 1, Admiralty Centre, 18 Harcourt Road, Admiralty, Hong Kong on Tuesday, 21 June 2016 at 3 : 00 p.m. and at any adjournment thereof for the purpose of considering and, if thought fit, passing the ordinary resolutions as set out in the notice convening the Meeting as indicated below or if no such indication is given, as my/our proxy thinks fit and in respect of any other business that may properly come before the Meeting and/or at any adjournment thereof:


ORDINARY RESOLUTIONS (Note4)

FOR (Note 5)

AGAINST (Note 5)

1.

To receive and consider the audited consolidated financial statements, the report of the directors of the Company (the ''Directors'') and the independent auditor's report thereon for the year ended 31 December 2015.

2.

To approve the recommended final dividend of HK5.99 cents per share of US$0.01 each in the capital of the Company out of the Company's share premium account for the year ended 31 December 2015.

3.

(i) To re-elect Mr. Lee Jin Yi as a non-executive Director.

(ii) To re-elect Mr. Liu Bang Min as an executive Director.

(iii) To re-elect Mr. Chan Kee Huen, Michael as an independent non-executive Director.

(iv) To re-elect Mr. Tang Chiu Ping, Raymond as an independent non-executive Director.

(v) To re-elect Ms. Liu Xue Zi as a non-executive Director.

(vi) To re-elect Mr. Hou Song as an executive Director.

(vii) To authorise the board (the ''Board'') of Directors to fix Directors' remuneration.

4.

To re-appoint BDO Limited as the auditor of the Company and to authorise the Board to fix its remuneration.

5.

(A) To grant a general mandate to the Directors to allot, issue and deal with additional shares not exceeding 20% of the issued share capital of the Company as at the date of passing this resolution.

(B) To grant a general mandate to the Directors to repurchase shares not exceeding 10% of the issued share capital of the Company as at the date of passing this resolution.

(C) To extend the general mandate granted to the Directors to allot, issue and deal with additional shares in the share capital of the Company by an amount not exceeding the amount of the shares repurchased by the Company.


Dated this day of 2016 Signature (note6)


Notes:

  1. Full name(s) and address(es) must be inserted in BLOCK CAPITALS. The names of all joint registered holders should be stated.

  2. Please insert the number of shares registered in your name(s) to which the proxy relates. If no number is inserted, this form of proxy will be deemed to relate to all the shares of the Company registered in your name(s).

  3. If any proxy other than the Chairman is preferred, please strike out ''the Chairman of the annual general meeting of the Company'' and insert the name and address of the proxy desired in the space provided. ANY ALTERATION MADE TO THIS FORM OF PROXY MUST BE INITIALLED BY THE PERSON(S) WHO SIGN(S) IT.

  4. The description of these resolutions is by way of summary only. The full text appears in the notice convening the Meeting.

  5. IMPORTANT: IF YOU WISH TO VOTE FOR THE RESOLUTION, TICK THE BOX MARKED ''FOR''. IF YOU WISH TO VOTE AGAINST THE RESOLUTION, TICK THE BOX MARKED ''AGAINST''. Failure to tick either box will entitle your proxy to cast your vote or abstain at his discretion. Your proxy will also be entitled to vote or abstain at his discretion on any resolution properly put to the Meeting and/or at any adjournment thereof other than those referred to in the notice convening the Meeting.

  6. This form of proxy shall be in writing under the hand of the appointor or of his attorney duly authorised in writing or, if the appointor is a corporation, either under its seal or under the hand of an officer, attorney or other person authorised to sign the same. In the case of this form of proxy purporting appointor to be signed on behalf of a corporation by an officer thereof it shall be assumed, unless the contrary appears, that such officer was duly authorised to sign this form on behalf of the corporation without

    further evidence of the fact.

  7. Any member entitled to attend and vote at the Meeting is entitled to appoint another person as his proxy to attend and vote instead of him. A member may appoint a proxy in respect of part only of his holding of shares in the Company. A proxy need not be a member of the Company.

  8. This form of proxy and (if required by the Board) the power of attorney or other authority (if any) under which it is signed, or a certified copy of such power or authority, shall be delivered to the office of the Hong Kong share registrar and transfer office of the Company, Tricor Investor Services Limited, at Level 22, Hopewell Centre, 183 Queen's Road East, Hong Kong not less than forty-eight (48) hours before the time appointed for holding the Meeting or adjourned meeting at which the person named in this form proposes to vote or, in the case of a poll taken subsequently to the date of the Meeting or adjourned meeting, not less than forty-eight (48) hours before the time appointed for the taking of the poll and in default this form of proxy shall not be treated as valid.

  9. Delivery of this form of proxy shall not preclude a member from attending and voting in person at the Meeting and in such event, this form of proxy shall be deemed to be revoked.

  10. Where there are joint holders of any share any one of such joint holders may vote, either in person or by proxy, in respect of such share as if he were solely entitled thereto, but if more than one of such joint holders be present at the meeting the vote of the senior who tenders a vote, whether in person or by proxy, shall be accepted to the exclusion of the votes of the other joint holders, and for this purpose seniority shall be determined by the order in which the names stand in the register of members of the Company in respect of the joint holding.

  11. The notice convening the Meeting is set out in the Company's circular dated 15 April 2016.

Lansen Pharmaceutical Holdings Co. Ltd. issued this content on 15 April 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 15 April 2016 07:19:19 UTC

Original Document: http://www.lansen.com.cn/Upload/OtherFiles/2016.4.15_15.5.49_1967.pdf